Statutory Instruments
2021 No. 286
National Health Service, England
The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2021
Made 9th March 2021
Laid before Parliament 11th March 2021
Coming into force 1st April 2021

The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 6E(1) and (2) and sections 272(7) and (8) of the National Health Service Act 2006.
2006 c.41. Section 6E was inserted by section 20(1) of the Health and Social Care Act 2012 (c.7).

Citation and Commencement
1. These Regulations may be cited as the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2021 and come into force on 1st April 2021.

Amendment of the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012
2. (1) The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 are amended as follows.
S.I. 2012/2996; relevant amending instruments are S.I. 2014/1611 and 2020/469.
(2) In regulation 20 (interpretation)—
(a) in the definition of “flat rate payment”, for “£183.92” substitute “£187.60”; and
(b) in the definition of “high band payment”, for “£253.02” substitute “£258.08”.
Signed by authority of the Secretary of State for Health and Social Care
Helen Whately
Minister of State
Department of Health and Social Care
9th March 2021

EXPLANATORY NOTE
(This note is not part of the Regulations)
The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 (S.I. 2012/2996) (“Standing Rules”) make provision for, amongst other things, NHS funded nursing care.
These Regulations amend Part 6 of the Standing Rules (NHS Continuing Healthcare and NHS Funded Nursing Care). The amendments made by regulation 2(2) increase the rates for NHS funded nursing care payable by the National Health Service Commissioning Board or a clinical commissioning group.
A full impact assessment has not been produced for this instrument as no, or no significant, impact on the private, voluntary or public sector is foreseen.